IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,727,629 | +181.4% | 655,371 | +154.5% | 0.03% | +188.9% |
| Q2 2023 | $10,564,158 | +4.7% | 257,474 | -8.8% | 0.01% | 0.0% |
| Q1 2023 | $10,090,331 | -19.0% | 282,326 | -14.4% | 0.01% | -18.2% |
| Q4 2022 | $12,457,943 | -13.0% | 329,837 | +1.9% | 0.01% | -15.4% |
| Q3 2022 | $14,312,000 | +36.9% | 323,586 | +14.6% | 0.01% | +30.0% |
| Q2 2022 | $10,454,000 | -4.3% | 282,382 | -4.2% | 0.01% | +25.0% |
| Q1 2022 | $10,920,000 | +26.2% | 294,815 | +3.7% | 0.01% | +33.3% |
| Q4 2021 | $8,655,000 | -10.4% | 284,424 | -1.3% | 0.01% | -14.3% |
| Q3 2021 | $9,664,000 | -24.5% | 288,128 | -10.2% | 0.01% | -30.0% |
| Q2 2021 | $12,792,000 | -10.1% | 320,680 | +1.3% | 0.01% | -9.1% |
| Q1 2021 | $14,233,000 | -16.3% | 316,577 | +5.2% | 0.01% | -15.4% |
| Q4 2020 | $17,008,000 | +20.3% | 300,806 | +0.9% | 0.01% | 0.0% |
| Q3 2020 | $14,139,000 | -17.5% | 297,983 | +2.5% | 0.01% | -23.5% |
| Q2 2020 | $17,138,000 | +26.5% | 290,676 | +1.4% | 0.02% | +6.2% |
| Q1 2020 | $13,548,000 | -25.9% | 286,553 | -5.3% | 0.02% | -5.9% |
| Q4 2019 | $18,283,000 | +4.7% | 302,653 | +3.9% | 0.02% | 0.0% |
| Q3 2019 | $17,456,000 | +25.0% | 291,371 | +34.1% | 0.02% | +6.2% |
| Q2 2019 | $13,969,000 | -18.2% | 217,356 | +3.3% | 0.02% | -23.8% |
| Q1 2019 | $17,079,000 | +67.9% | 210,408 | +11.8% | 0.02% | +50.0% |
| Q4 2018 | $10,170,000 | -0.0% | 188,123 | -4.6% | 0.01% | +7.7% |
| Q3 2018 | $10,172,000 | +15.2% | 197,200 | -6.9% | 0.01% | +8.3% |
| Q2 2018 | $8,830,000 | -21.2% | 211,900 | -16.6% | 0.01% | -25.0% |
| Q1 2018 | $11,201,000 | -16.4% | 254,100 | -4.6% | 0.02% | -11.1% |
| Q4 2017 | $13,395,000 | +18.5% | 266,300 | +19.5% | 0.02% | +5.9% |
| Q3 2017 | $11,301,000 | +1.3% | 222,900 | +1.6% | 0.02% | -5.6% |
| Q2 2017 | $11,156,000 | +29.4% | 219,300 | +2.2% | 0.02% | +28.6% |
| Q1 2017 | $8,623,000 | -19.4% | 214,500 | -4.2% | 0.01% | -22.2% |
| Q4 2016 | $10,704,000 | +30.5% | 223,800 | 0.0% | 0.02% | +38.5% |
| Q3 2016 | $8,200,000 | +47.2% | 223,800 | -6.4% | 0.01% | +44.4% |
| Q2 2016 | $5,571,000 | -44.2% | 239,200 | -3.0% | 0.01% | -43.8% |
| Q1 2016 | $9,991,000 | -41.1% | 246,700 | -9.9% | 0.02% | -40.7% |
| Q4 2015 | $16,963,000 | – | 273,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |